|
FR5528E
(fr)
|
1905-03-16 |
1906-05-02 |
Farcot Freres Et Cie Soc |
Perfectionnements aux turbines à vapeur ou à gaz
|
|
DE1118403B
(de)
|
1960-01-27 |
1961-11-30 |
Hoechst Ag |
Verfahren zur Gewinnung von antitumorwirksamen Sporen
|
|
FR1275M
(fr)
|
1961-05-06 |
1962-05-02 |
Rene Roger |
Médicament a base de colibacilles vivants.
|
|
NL294835A
(pl)
|
1962-07-19 |
1900-01-01 |
|
|
|
FR2828M
(fr)
|
1963-03-01 |
1964-11-02 |
Lucien Nouvel |
Médicament renfermant des colibacilles antibiorésistants.
|
|
GB1271674A
(en)
|
1968-07-09 |
1972-04-26 |
Nisshin Flour Milling Co |
Process and preparation for treating diarrhoea in pigs
|
|
SE371209B
(pl)
|
1969-10-13 |
1974-11-11 |
Cernelle Ab |
|
|
DE2134179A1
(de)
|
1971-07-09 |
1973-01-25 |
Rolf Dr Schuler |
Bifidobakterien enthaltendes praeparat und verfahren zur herstellung desselben
|
|
FR2244464A1
(en)
|
1973-06-26 |
1975-04-18 |
Serozym Laboratoires |
Yeast, lacto- and colibacillus based compsns - used to modify intestinal flora, treat colitis and digestive disorders, etc.
|
|
US4098728A
(en)
|
1976-01-02 |
1978-07-04 |
Solomon Rosenblatt |
Medical surgical sponge and method of making same
|
|
US4335107A
(en)
|
1978-06-05 |
1982-06-15 |
Snoeyenbos Glenn H |
Mixture to protect poultry from salmonella
|
|
CH637297A5
(fr)
|
1978-12-05 |
1983-07-29 |
Nestle Sa |
Microbille comprenant un microorganisme et son procede de fabrication.
|
|
US4309782A
(en)
|
1980-09-11 |
1982-01-12 |
Esteban Paulin |
Device for collecting fecal specimens
|
|
US4536409A
(en)
|
1981-01-23 |
1985-08-20 |
American Can Company |
Oxygen scavenger
|
|
US4394377A
(en)
|
1981-07-31 |
1983-07-19 |
Syntex (U.S.A.) Inc. |
Ruminant animal performance by co-administering choline and propionate enchancers
|
|
US4452779A
(en)
|
1982-02-03 |
1984-06-05 |
Cockerill Vernon |
Composition and method of treating lactating mammals
|
|
FI840816A0
(fi)
|
1984-03-01 |
1984-03-01 |
Farmos Oy |
Bakteriepreparat
|
|
JPS615022A
(ja)
|
1984-06-19 |
1986-01-10 |
Advance Res & Dev Co Ltd |
腸内細菌叢改善剤
|
|
US4892731A
(en)
|
1986-12-11 |
1990-01-09 |
Tadashi Arai |
Biological intestinal antiseptics
|
|
IL86859A
(en)
|
1987-07-10 |
1991-12-15 |
E Z Em Inc |
Aqueous cathartic solution containing inorganic salts
|
|
US4948734A
(en)
|
1987-08-12 |
1990-08-14 |
Mycogen Corporation |
Novel isolates of bacillus thuringiensis having activity against nematodes
|
|
DE68928665T2
(de)
|
1988-08-02 |
1998-11-12 |
Gastro Services Pty Ltd |
Behandlung von gastro-intestinalen krankheiten
|
|
US5443826A
(en)
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
|
US5213807A
(en)
|
1990-05-03 |
1993-05-25 |
Chemburkar Pramod B |
Pharmaceutical composition containing ibuprofen and a prostaglandin
|
|
JP2961184B2
(ja)
|
1990-05-07 |
1999-10-12 |
ミヤリサン株式会社 |
クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物
|
|
US5266315A
(en)
|
1990-05-07 |
1993-11-30 |
Kabushiki Kaisha Miyarisan Seibutsu Igaku Kenkyusho |
Composite for Clostridium difficile diarrhea and pseudomembranous colitis
|
|
GB9107305D0
(en)
|
1991-04-08 |
1991-05-22 |
Unilever Plc |
Probiotic
|
|
JP3047143B2
(ja)
|
1992-04-24 |
2000-05-29 |
堀井薬品工業株式会社 |
腸管洗浄液用組成物及び腸管洗浄液
|
|
JP3850891B2
(ja)
|
1994-03-01 |
2006-11-29 |
ゼリア新薬工業株式会社 |
緩下効果を有する組成物
|
|
US6984513B2
(en)
|
1994-03-03 |
2006-01-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Anaerobe targeted enzyme-mediated prodrug therapy
|
|
JPH07242557A
(ja)
|
1994-03-03 |
1995-09-19 |
Ss Pharmaceut Co Ltd |
乳酸菌含有瀉下薬組成物
|
|
AU686389B2
(en)
|
1994-05-26 |
1998-02-05 |
Dibra S.P.A. |
Lactobacillus strains of human origin, their compositions and uses thereof
|
|
US5599795A
(en)
|
1994-08-19 |
1997-02-04 |
Mccann; Michael |
Method for treatment of idiopathic inflammatory bowel disease (IIBD)
|
|
AUPM864894A0
(en)
|
1994-10-07 |
1994-11-03 |
Borody, Thomas Julius |
Treatment of bowel-dependent neurological disorders
|
|
US5800821A
(en)
|
1995-03-10 |
1998-09-01 |
New England Medical Center Hospitals, Inc. |
Bacterial spores as a heat stable vaccine delivery system
|
|
US7048906B2
(en)
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
|
US5858356A
(en)
|
1995-12-21 |
1999-01-12 |
Abbott Laboratories |
Lactobacillus acidophilus to inhibit cryptosporidiosis in mammals
|
|
US5902578A
(en)
|
1996-03-25 |
1999-05-11 |
Abbott Laboratories |
Method and formula for the prevention of diarrhea
|
|
US5837238A
(en)
|
1996-06-05 |
1998-11-17 |
Biogaia Biologics Ab |
Treatment of diarrhea
|
|
US6087386A
(en)
|
1996-06-24 |
2000-07-11 |
Merck & Co., Inc. |
Composition of enalapril and losartan
|
|
AU1819897A
(en)
|
1996-09-26 |
1998-04-17 |
Cuperman, Vladimir Borisovich |
Medicinal prophylactic "trisan"
|
|
US5948787A
(en)
|
1997-02-28 |
1999-09-07 |
Alza Corporation |
Compositions containing opiate analgesics
|
|
US6162464A
(en)
|
1997-03-31 |
2000-12-19 |
Inkine Pharmaceutical, Inc. |
Non-aqueous colonic purgative formulations
|
|
US7374753B1
(en)
|
1997-06-03 |
2008-05-20 |
Ganeden Biotech, Inc. |
Probiotic lactic acid bacterium to treat bacterial infections associated with SIDS
|
|
US6428783B1
(en)
|
1998-03-11 |
2002-08-06 |
Medtech Center, Inc. |
Bank of autochthonous strains of microorganisms and methods of its use for recovery of intestinal microbiocenosis of the men
|
|
US5902743A
(en)
|
1998-03-20 |
1999-05-11 |
Wisconsin Alumni Research Foundation |
Probiotic bifidobacterium strain
|
|
AU771630B2
(en)
|
1998-05-06 |
2004-04-01 |
Keijiro Nakamura |
Microbial culture liquors containing microorganisms differing in characteristics and living in symbiosis and metabolites thereof, carriers and adsorbents containing the active components of the culture liquors and utilization of the same
|
|
US6368591B2
(en)
|
1998-05-15 |
2002-04-09 |
Shanghai Sine Pharmaceutical Corporation Ltd. |
Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
|
|
AT407008B
(de)
|
1998-08-06 |
2000-11-27 |
Viernstein Helmut Dr |
Formulierungen mit probiotisch wirksamen mikroorganismen
|
|
US6461607B1
(en)
|
1998-08-24 |
2002-10-08 |
Ganeden Biotech, Inc. |
Probiotic, lactic acid-producing bacteria and uses thereof
|
|
CZ2001951A3
(cs)
|
1998-09-17 |
2001-11-14 |
Baxter Healthcare S. A. |
Prostředky obsahující streptokokový Cbeta protein
|
|
EP1005863A1
(en)
|
1998-12-04 |
2000-06-07 |
Synthelabo |
Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
|
|
AU1543400A
(en)
|
1998-12-11 |
2000-07-03 |
Urex Biotech Inc. |
Oral administration of lactobacillus for the treatment and prevention of urogenital infection
|
|
US6245740B1
(en)
|
1998-12-23 |
2001-06-12 |
Amgen Inc. |
Polyol:oil suspensions for the sustained release of proteins
|
|
ID29150A
(id)
|
1999-01-15 |
2001-08-02 |
Entpr Ireland Cs |
Penggunaan lactobacillus salivarius
|
|
DE60040214D1
(de)
|
1999-02-26 |
2008-10-23 |
Shionogi & Co |
Kaubare weichkapseln mit verbesserten verabreichungseigenschaften sowie verfahren zu deren herstellung
|
|
FR2808689B1
(fr)
|
2000-05-11 |
2004-09-03 |
Agronomique Inst Nat Rech |
Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs
|
|
US20040062757A1
(en)
|
2001-06-05 |
2004-04-01 |
Finegold Sydney M. |
Method of testing gastrointestinal diseases associated with species of genus clostridium
|
|
US20040170617A1
(en)
|
2000-06-05 |
2004-09-02 |
Finegold Sydney M. |
Method of treating diseases associated with abnormal gastrointestinal flora
|
|
US20020013270A1
(en)
|
2000-06-05 |
2002-01-31 |
Bolte Ellen R. |
Method for treating a mental disorder
|
|
US6756032B1
(en)
|
2000-07-12 |
2004-06-29 |
The Procter & Gamble Company |
Method to enhance and/or prolong the effects of a primary challenge to a responsive system with a secondary challenge
|
|
EP1303285A2
(en)
|
2000-07-17 |
2003-04-23 |
Chr. Hansen A/S |
Methods and formulations with probiotic microorganisms and medicaments
|
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
US7214370B2
(en)
|
2000-12-18 |
2007-05-08 |
Probiohealth, Llc |
Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
|
|
US6790453B2
(en)
|
2001-03-14 |
2004-09-14 |
Mccormick & Company, Inc. |
Encapsulation compositions and process for preparing the same
|
|
US7815956B2
(en)
|
2001-04-27 |
2010-10-19 |
Pepsico |
Use of erythritol and D-tagatose in diet or reduced-calorie beverages and food products
|
|
US6926907B2
(en)
|
2001-06-01 |
2005-08-09 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
|
CA2452577C
(en)
|
2001-07-05 |
2011-04-19 |
Wakunaga Pharmaceutical Co., Ltd. |
Soft capsules
|
|
PE20030284A1
(es)
|
2001-07-26 |
2003-05-01 |
Alimentary Health Ltd |
Cepas de bifidobacterium
|
|
US20030092724A1
(en)
|
2001-09-18 |
2003-05-15 |
Huaihung Kao |
Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic
|
|
GB0124580D0
(en)
|
2001-10-12 |
2001-12-05 |
Univ Reading |
New composition
|
|
EP2308475A1
(en)
|
2002-04-05 |
2011-04-13 |
Euro-Celtique S.A. |
Matrix for sustained, invariant and independent release of active compounds
|
|
CA2391422A1
(en)
|
2002-07-12 |
2004-01-12 |
David William Molloy |
Rifampin (rifadin, rimactone, rifampicin) and doxycycline, (doryx, vibramycin) and the tetracyclines and other compounds currently classified as antibiotics and anti-tuberculous drugs as a treatment to prevent, modify disease progression and/or improve symptoms for neurodegenerative diseases including alzheimers disease, lewy body dementia, schizophrenia,...
|
|
IL152127A0
(en)
|
2002-10-06 |
2003-05-29 |
Bio Balance Corp |
Probiotic compositions for the treatment of inflammatory bowel disease
|
|
EP1656025A4
(en)
|
2003-08-18 |
2007-12-05 |
Bio Balance Corp |
STABLE LIQUID PROBIOTIC COMPOSITION, PREPARATION AND CORRESPONDING APPLICATIONS
|
|
US7759105B2
(en)
|
2003-08-29 |
2010-07-20 |
Cobb & Company, Llp |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
|
US7749509B2
(en)
|
2003-08-29 |
2010-07-06 |
Cobb And Company, Llp |
Treatment of autism using probiotic composition
|
|
US20060177424A1
(en)
|
2003-08-29 |
2006-08-10 |
Cobb Mark L |
Treatment of disease states and adverse physiological conditions utilizing anti-fungal compositions
|
|
US8192733B2
(en)
|
2003-08-29 |
2012-06-05 |
Cobb & Associates |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
|
US8016816B2
(en)
|
2003-09-09 |
2011-09-13 |
Convatec Technologies Inc. |
Fecal management appliance and method and apparatus for introducing same
|
|
US7541091B2
(en)
|
2004-05-18 |
2009-06-02 |
M & G Usa Corporation |
Compartmentalized resin pellets for oxygen scavenging
|
|
ATE367821T1
(de)
|
2004-08-05 |
2007-08-15 |
Anidral Srl |
Folsäure produzierende bifidobacterium bakterienstämme, ihre formulierungen und verwendung
|
|
ES2290762T3
(es)
|
2004-08-05 |
2008-02-16 |
Anidral S.R.L. |
Cepas bacterianas de bifidobacterium que producen acido folico, sus formulaciones y utilizacion.
|
|
US20070254314A1
(en)
*
|
2004-09-16 |
2007-11-01 |
Geier Mark R |
Methods of treating autism and autism spectrum disorders
|
|
KR20070046185A
(ko)
*
|
2004-09-23 |
2007-05-02 |
메르츠 파마 게엠베하 운트 코. 카가아 |
소아 행동장애의 치료를 위한 메만틴
|
|
US20060076536A1
(en)
|
2004-09-29 |
2006-04-13 |
Barshied Scott R |
Oxygen scavenging pharmaceutical package and methods for making same
|
|
US20060115465A1
(en)
|
2004-10-29 |
2006-06-01 |
Macfarlane George |
Treatment of gastrointestinal disorders
|
|
DK1885343T3
(da)
|
2005-05-20 |
2012-01-16 |
Dow Global Technologies Llc |
Overvågning af en oral lægemiddelcompliance ved anvendelse af radiofrekvensidentifikationsmærker (RFID tags)
|
|
US20060275223A1
(en)
|
2005-06-02 |
2006-12-07 |
Burr James B |
Erythritol compositions for teeth and gums
|
|
TWI362949B
(en)
|
2005-09-13 |
2012-05-01 |
Bion Tech Inc |
Intestines dissolving nature is able to bear the hydrochloric acid in gastric juice and wrap up the benefit covered and grow the fungus of makes up
|
|
EP1970055B1
(en)
|
2005-12-29 |
2010-11-24 |
Osmotica Kereskedelmi És Szolgáltató Kft |
Multi-layered tablet with triple release combination
|
|
JP5006567B2
(ja)
|
2006-04-14 |
2012-08-22 |
花王株式会社 |
口腔用固形製剤
|
|
US7998510B2
(en)
|
2006-08-17 |
2011-08-16 |
C. B. Fleet Company, Inc. |
Low dose colonic cleansing system
|
|
JP2008106066A
(ja)
|
2006-09-25 |
2008-05-08 |
Tashiro Yasuaki |
サポニン及び生菌を含有する組成物
|
|
DE102006062250A1
(de)
|
2006-12-22 |
2008-06-26 |
Roland Saur-Brosch |
Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
|
|
DK2136825T3
(da)
|
2007-03-01 |
2014-02-24 |
Probi Ab |
Anvendelse af Lactobacillus plantarum til forøgelse af bakteriediversiteten
|
|
JP5538209B2
(ja)
|
2007-03-28 |
2014-07-02 |
アリメンタリー・ヘルス・リミテッド |
プロバイオティック性のビフィドバクテリウム菌株
|
|
US8709398B2
(en)
|
2007-03-28 |
2014-04-29 |
Alimentary Health Limited |
Probiotic Bifidobacterium strains
|
|
EP2155167A2
(en)
|
2007-06-04 |
2010-02-24 |
Egalet A/S |
Controlled release pharmaceutical compositions for prolonged effect
|
|
MX2009013063A
(es)
|
2007-06-06 |
2010-01-15 |
Basf Se |
Formulacion farmaceutica para la produccion de tabletas de desintegracion rapida.
|
|
WO2008148734A1
(de)
|
2007-06-06 |
2008-12-11 |
Basf Se |
Pharmazeutische formulierung für die herstellung von kau- und lutsch-tabletten
|
|
WO2009016133A1
(en)
|
2007-07-27 |
2009-02-05 |
Cargill, Incorporated |
Micronization of polyols
|
|
EP2030623A1
(en)
|
2007-08-17 |
2009-03-04 |
Nestec S.A. |
Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
|
|
ATE548423T1
(de)
|
2007-08-31 |
2012-03-15 |
Invista Tech Sarl |
Sauerstoffabsorbierende kunststoffzusammensetzungen
|
|
WO2009041651A1
(ja)
|
2007-09-27 |
2009-04-02 |
Mitsubishi Tanabe Pharma Corporation |
速崩壊性固形製剤
|
|
EP2572705B1
(en)
|
2007-10-01 |
2017-09-13 |
Laboratorios Lesvi, S.L. |
Orodispersible tablets
|
|
WO2009052391A1
(en)
|
2007-10-19 |
2009-04-23 |
Purdue Research Foundation |
Solid formulations of crystalline compounds
|
|
EP2203551B1
(en)
|
2007-10-20 |
2013-08-21 |
Université de Liège |
Bifidobacterial species
|
|
WO2009055362A1
(en)
|
2007-10-26 |
2009-04-30 |
Moore Brenda E |
Probiotic compositions and methods for inducing and supporting weight loss
|
|
JP5258268B2
(ja)
|
2007-11-19 |
2013-08-07 |
フロイント産業株式会社 |
球形粒の製造方法
|
|
WO2009084678A1
(ja)
|
2007-12-28 |
2009-07-09 |
Sawai Pharmaceutical Co., Ltd. |
口腔内崩壊錠およびその製造方法
|
|
CN101496819A
(zh)
|
2008-01-31 |
2009-08-05 |
青岛东海药业有限公司 |
真杆菌、梭菌制剂及其应用
|
|
KR100913405B1
(ko)
|
2008-03-25 |
2009-08-21 |
광주과학기술원 |
Ｔｈ２－매개 면역 질환의 예방 또는 치료용 조성물
|
|
US8586029B2
(en)
|
2008-06-04 |
2013-11-19 |
Trustees Of Dartmouth College |
Prevention or treatment of immune-relevant disease by modification of microfloral populations
|
|
WO2010040020A1
(en)
|
2008-10-02 |
2010-04-08 |
Salix Pharmaceuticals, Ltd. |
Methods of treating hepatic encephalopathy
|
|
US20100178413A1
(en)
|
2008-12-17 |
2010-07-15 |
Mark Gorris |
Food-based Supplement Delivery System
|
|
WO2010103132A1
(es)
|
2009-03-10 |
2010-09-16 |
Hero España, S.A. |
Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
|
|
US20100255231A1
(en)
|
2009-04-01 |
2010-10-07 |
Multisorb Technologies, Inc. |
Oxygen scavenging films
|
|
EP2424972B1
(en)
|
2009-04-30 |
2013-07-24 |
Actogenix N.V. |
Cryoprotectants for freeze drying of lactic acid bacteria
|
|
US20100285164A1
(en)
|
2009-05-11 |
2010-11-11 |
Jrs Pharma |
Orally Disintegrating Excipient
|
|
US20120064133A1
(en)
|
2009-05-28 |
2012-03-15 |
Ishwar Chauhan |
Multiparticulate Controlled-Release Selective Serotonin Reuptake Inhibitor Formulations
|
|
CN201441672U
(zh)
|
2009-07-14 |
2010-04-28 |
赵伟华 |
一次性灌肠装置
|
|
US20110045222A1
(en)
|
2009-08-19 |
2011-02-24 |
Eastman Chemical Company |
Oxygen-scavenging polymer blends suitable for use in packaging
|
|
GB0916335D0
(en)
|
2009-09-17 |
2009-10-28 |
Martin W J |
Medicaments
|
|
US20110081320A1
(en)
|
2009-10-06 |
2011-04-07 |
Nubiome, Inc. |
Treatment/Cure of Autoimmune Disease
|
|
EP2485744A4
(en)
*
|
2009-10-09 |
2014-01-22 |
Prothera Inc |
COMPOSITIONS AND METHODS COMPRISING THE PEDIOCOCCUS TO REDUCE AT LEAST ONE SYMPTOM ASSOCIATED WITH DEVELOPMENT-INVASIVE DISORDER IN A PERSON IN WHICH A DEVELOPMENT-INVASIVE DISORDER HAS BEEN DIAGNOSED
|
|
US20120276149A1
(en)
|
2009-10-15 |
2012-11-01 |
Dan Littman |
Methods for modulating bacterial infection
|
|
PL2823822T3
(pl)
|
2009-11-11 |
2017-09-29 |
Alimentary Health Limited |
Szczep Bifidobakterium
|
|
JP5914357B2
(ja)
*
|
2010-01-15 |
2016-05-11 |
インセルム（インスティチュート ナショナル デ ラ サンテ エ デ ラ リシェルシェ メディカル） |
自閉症の治療のための化合物
|
|
US20110218216A1
(en)
|
2010-01-29 |
2011-09-08 |
Kumaravel Vivek |
Extended release pharmaceutical composition of donepezil
|
|
PL3564357T3
(pl)
|
2010-02-01 |
2022-08-08 |
Rebiotix, Inc. |
Bakterioterapia zapalenia jelita grubego z clostridium difficile
|
|
US7888062B1
(en)
|
2010-02-01 |
2011-02-15 |
Microbios, Inc. |
Process and composition for the manufacture of a microbial-based product
|
|
US8853269B2
(en)
|
2010-02-04 |
2014-10-07 |
Copperhead Chemical Company Inc. |
Composition and method for treating infections and promoting intestinal health
|
|
MX2012010482A
(es)
|
2010-03-10 |
2013-03-12 |
Nogra Pharma Ltd |
Composiciones para lavado de colon y metodos de elaboracion y uso de las mismas.
|
|
US9707207B2
(en)
*
|
2010-05-26 |
2017-07-18 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Method for diagnosing, preventing, and treating neurological diseases
|
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
|
|
EP2598155A2
(en)
|
2010-07-26 |
2013-06-05 |
Suomen Punainen Risti Veripalvelu |
Use of blood group status iii
|
|
US20120020941A1
(en)
|
2010-07-26 |
2012-01-26 |
Suomen Punainen Risti Veripalvelu |
Use of blood group status iii
|
|
CA2807242C
(en)
|
2010-08-04 |
2017-05-02 |
Thomas Julius Borody |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
|
EP2646567A4
(en)
|
2010-10-04 |
2014-03-26 |
British Columbia Cancer Agency |
DETECTION OF FUSOBACTERIUM IN A GASTROINTESTINAL SAMPLE TO DIAGNOSE GASTROINTESTINAL CANCER
|
|
LT3072524T
(lt)
|
2010-10-07 |
2018-03-26 |
California Institute Of Technology |
Probiotikai, skirti autizmo gydymui
|
|
WO2014152484A1
(en)
*
|
2013-03-14 |
2014-09-25 |
Regents Of The University Of Minnesota |
Freeze dried fecal microbiota for use in fecal microbial transplantation
|
|
US20150374761A1
(en)
|
2011-03-09 |
2015-12-31 |
Regents Of The University Of Minnesota |
Freeze dried fecal microbiota for use in fecal microbial transplantation
|
|
EP3610881A1
(en)
|
2011-03-09 |
2020-02-19 |
Regents Of The University Of Minnesota |
Compositions and methods for transplantation of colon microbiota
|
|
EP2744890A4
(en)
|
2011-09-14 |
2015-07-08 |
Univ Kingston |
METHOD FOR TREATING DISORDERS OF THE GASTROINTESTINAL DEVICE
|
|
PT2750682T
(pt)
|
2011-10-11 |
2016-07-26 |
Achim Biotherapeutics Ab |
Composição compreendendo a flora intestinal cultivada anaerobiamente
|
|
CN108676774B
(zh)
|
2011-12-01 |
2023-05-09 |
国立大学法人东京大学 |
诱导调节性t细胞的增殖或积累的人源细菌
|
|
US9176026B2
(en)
|
2011-12-15 |
2015-11-03 |
Pureflora, Inc. |
Device for the collection, refinement, and administration of gastrointestinal microflora
|
|
EP2609814A1
(en)
*
|
2011-12-30 |
2013-07-03 |
Nestec S.A. |
Lactobacillus reuteri DSM 17938 for the development of cognitive function
|
|
US8993260B2
(en)
|
2012-05-02 |
2015-03-31 |
Charles River Laboratories, Inc. |
Fluorescence-based viability staining method using a membrane permeable flourescent dye and membrane impermeable fluorescence quencher
|
|
US9719144B2
(en)
|
2012-05-25 |
2017-08-01 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
|
CN104768560A
(zh)
|
2012-08-29 |
2015-07-08 |
加州理工学院 |
孤独症谱系障碍的诊断和治疗
|
|
EP2914135A1
(en)
|
2012-11-01 |
2015-09-09 |
Rijksuniversiteit Groningen |
Methods and compositions for stimulating beneficial bacteria in the gastrointestinal tract
|
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
CA2896795A1
(en)
|
2012-11-26 |
2014-05-30 |
Thomas Julius Borody |
Compositions for the restoration of a fecal microbiota and methods for making and using them
|
|
BR122021010444B1
(pt)
|
2013-02-04 |
2022-07-12 |
Seres Therapeutics, Inc |
Composição terapêutica compreendendo uma população purificada de bactérias formadoras de esporos, método para a produção da composição e uso da composição
|
|
US20140243175A1
(en)
|
2013-02-26 |
2014-08-28 |
Ming-Chih Huang |
Fitness chair
|
|
AU2014239883B2
(en)
|
2013-03-14 |
2019-01-17 |
Therabiome, Llc |
Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
|
|
CN105307654B
(zh)
|
2013-04-30 |
2022-06-07 |
托马斯·朱利叶斯·波洛迪 |
用于治疗微生物区系相关的精神病况和疾病的组合物和方法
|
|
HUE040211T2
(hu)
*
|
2013-06-05 |
2019-02-28 |
Rebiotix Inc |
Mikrobióta-helyreállítási terápia (MRT), készítmények és elõállítási eljárások
|
|
US9782445B2
(en)
|
2013-06-05 |
2017-10-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
|
US9511100B2
(en)
*
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
|
US9511099B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
|
WO2015006355A2
(en)
|
2013-07-09 |
2015-01-15 |
Puretech Ventures, Llc |
Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
|
|
AU2014331610B2
(en)
|
2013-10-03 |
2019-11-07 |
Trustees Of The University Of Pennsylvania |
Compositions comprising a defined microbiome and methods of use thereof
|
|
AU2014352643A1
(en)
|
2013-11-25 |
2016-06-30 |
Seres Therapeutics, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
EP3082431A4
(en)
|
2013-12-16 |
2017-11-15 |
Seres Therapeutics, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
|
EP3107553B1
(en)
|
2014-02-18 |
2021-12-01 |
Universitätsklinikum Jena |
Methods and compositions for intestinal microenvironment transfer
|
|
US10293004B2
(en)
|
2014-03-28 |
2019-05-21 |
Kabushiki Kaisha Yakult Honsha |
Butyrate-producing bacterium and use thereof
|
|
US9176113B1
(en)
|
2014-04-11 |
2015-11-03 |
Synapdx Corporation |
Methods and systems for determining autism spectrum disorder risk
|
|
US20150294081A1
(en)
|
2014-04-11 |
2015-10-15 |
Synapdx Corporation |
Methods and systems for determining autism spectrum disorder risk
|
|
SE1550189A1
(en)
|
2015-02-19 |
2016-08-20 |
Achim Biotherapeutics Ab |
Therapeutic and prophylactic composition produced by microbiota
|
|
EP3294307A4
(en)
|
2015-05-14 |
2019-01-23 |
Crestovo Holdings Llc |
COMPOSITIONS FOR TRANSPLANTATION OF FECAL FLORA AND METHODS OF PREPARATION AND USE THEREOF, AND DEVICES FOR THEIR ADMINISTRATION
|
|
ES2909456T3
(es)
|
2015-05-22 |
2022-05-06 |
Univ Arizona State |
Métodos para tratar el trastorno del espectro autista y síntomas asociados
|
|
CA3003138A1
(en)
|
2015-10-26 |
2017-05-04 |
Crestovo Holdings Llc |
Compositions and methods for fecal microbiota-related therapy
|
|
CN115919906A
(zh)
|
2016-03-04 |
2023-04-07 |
加利福尼亚大学董事会 |
微生物聚生体及其用途
|
|
CA3026414A1
(en)
|
2016-06-01 |
2017-12-07 |
Crestovo Holdings Llc |
Compositions and methods for treating inflammatory bowel diseases (ibds) and other disorders
|
|
US20170360848A1
(en)
|
2016-06-15 |
2017-12-21 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods for treating autism spectrum disorder and associated symptoms
|
|
US20200061127A1
(en)
|
2016-11-11 |
2020-02-27 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods and Compositions for Changing Metabolite Levels in a Subject
|